References and Research Abstracts Supporting Joint Rescue
1. Raskin JB. Gastrointestinal effects of nonsteroidal anti-inflammatory therapy. Am J Med 1999; 106(5B):3S- 12S
2. Singh G, Rosen Ramey D. NSAID induced gastrointestinal complications: the ARAMIS perspective-1997. Arthritis, Rheumatism, and Aging Medical Information System. J Rheumatol Suppl 1998; 51:8-16
3. Simon LS. The evolution of arthritis antiinflammatory care: where are we today? J Rheumatol 1999; 26 Suppl56:11-7
4. Sheild MJ. Anti-inflammatory drugs and their effects on cartilage synthesis and renal function. Eur J Rheumatol Inflamm 1993; 13(1):7-16
5. Field TS, Gurwitz JH, Glynn RJ, et al. The renal effects of nonsteroidal anti-inflammatory drugs in older people: findings from the Established Populations for Epidemiologic Studies of the Elderly. J Am Geriatr Soc 1999; 47(5):507-11
6. Blantz RC. Acetaminophen: acute and chronic renal function. Am J Kidney Dis 1996; 28(Suppl 1):S3-6
7. Roach JA, Stacey B. Acetaminophen toxicity. Orthop Nurs 1997; 16(3):49-53
8. Brandt KD. Effects of nonsteroidal anti-inflammatory drugs on chondrocyte metabolism in vitro and in vivo. Am J Med 1987; 83(5A):29-34
9. Redini F, Mauviel A, Loyau G, Pujol JP. Modulation of extracellular matrix metabolism in rabbit articular chondrocytes and human rheumatoid synovial cells by the non-steroidal anti-inflammatory drug etodolac. II: Glycosaminoglycan synthesis. Agents Actions 1990; 31(3-4):358-67
10.Dekel S, Falconer J, Francis MJ.The effects of anti-inflammatory drugs on glycosaminoglycan sulphation in pig cartilage. Prostaglandins Med 1980; 4(3):133-40
11. Hugenberg ST, Brandt KD, Cole CA. Effect of sodium salicylate, aspirin, and ibuprofen on enzymes required by the chondrocyte for synthesis of chondroitin sulfate. J Rheumatol 1993; 20(12):2128-33
12.Roden L.Effect of hexosamine on the synthesis of chondroitin sulpheric acid in vitro. Arkiv For Kemi 1956; 10(23):345-353
13. Karzel K, Domenjoz R. Effects of Hexosamine Derivatives and Uronic Acid Derivatives on Glycosaminoglycane Metabolism of Fibroblast Cultures. Pharmacology 1971; 5:337-345
14. Kim JJ, Conrad HE. Effect of D-Glucosamine Concentration on the Kinetics of Mucopolysaccharide Biosynthesis in Cultured Chick Embryo Vertebral Cartilage. J Biol Chem 1974; 249(10):3091-7
15. Vidal y Plana RR, Bizzarri D, Rovati AL. Articular Cartilage Pharmacology: I. In vitro studies on glucosamine and non steroidal antiinflammatory drugs. Pharmacol Res Com 1978; 10(6):557-569
16. Setnikar I, Giachetti C, Zanolo G. Absorption, distribution and excretion of radioactivity after a single inravenous or oral administration of [14C] glucosamine to the rat. Pharmatherapeutica 1984; 3(8):538-50
17. Setnikar I, Giacchetti C, Zanolo G. Pharmacokinetics of glucosamine in the dog and in man. Arzneimittelforschung 1986; 36(4):729-35
18. Setnikar I, Palumbo R, Canali S, Zanolo G. Pharmacokinetics of glucosamine in man. Arzneimittelforschung 1993; 43(10); 1109-1319. McCarty MF
19. Enhanced synovial production of hyaluronic acid may explain rapid clinical response to high-dose glucosamine in osteoarthritis. Med Hypothesis 1998; 50(6):507-10
20.Vaz AL. Double-blind clinical evaluation of the relative efficacy of ibuprofen and glucosamine sulphate in the management of osteoarthrosis of the knee in out-patients. Current Med Res and Opinion 1982; 8:145
21. Tapadinhas MJ, Rivera IC, Bignamini AA. Oral glucosamine sulphate in the management of arthrosis: Report on a multi-center open investigation in Portugal. Pharmatherapeutica 1982; 3:157
22. Vajaradul Y. Double-blind clinical evaluation of intra-articular glucosamine in outpatients with gonarthrosis. Clinical Therapeutical 1981; 3(5):
23. Pujalte JM, Llavore EP,Ylescupidez FR. Double-blind clinical evaluation of oral glucosamine sulphate in the basic treatment of osteoarthrosis. Current Med Res and Opinion 1980; 7:110
24. Crolle G, D’Estes E. Glucosamine sulphate for the management of arthrosis: a controlled clinical investigation. Curr Med Res Opinion 1980; 7:104
25. D’Ambrosia, Casa B, et al. Glucosamine Sulphate: a controlled clinical investigation in arthrosis. Pharmatherapeutica 1981; 2:504
26. Drovanti A, Bignamini AA,Rovati AL. Therapeutic activity of oral glucosamine sulfate in osteoarthrosis: a placebo-controlled double-blind investigation. Clinical Therapeutics 1980; 3(4)
27. McCarty MF,Glucosamine may retard atherogenesis by promoting endothelial production of heparin sulfate proteoglycans. Med Hypothese 1997; 48(3):245-51
28. Qiu GX, Gao SN, Giacovelli G et al. Efficacy and safety of glucosamine sulfate versus ibuprofen in patient with knee osteoarthritis. Arzneimittelforschung 1998; 48(5):469-74
29. Bassleer C, Rovati L, Franchimont P. Stimulation of proteoglycan production by glucosamine sulfate in chondrocytes isolated from human osteoarthritic articular cartilage in vitro. Osteoarthritis Cartilage 1998; 6(6):427-34
30. Gottlieb MS. Conservative management of spinal osteoarthritis with glucosamine sulfate and chiropractic treatment. J Manipulative Physiol Ther 1997; 20(6):400-14
31.da Camara CC,Dowless GV.Glucosamine sulfate for osteoarthritis. Ann Pharmacother 1998;
32(5):580- 7 32. Russell AL.Glucosamine in osteoarthritis and gastrointestinal disorders: an exemplar of the need for a paradigm shift. Med Hypothesis 1998; 51(4):347-9
33. Barclay TS, Tsourounis C, McCart GM. Glucosamine. Ann Pharmacother 1998; 32(5):574-9
34. Palmieri L, Conte A, Giovannini L, et al. Metabolic fate of exogenous chondroitin sulfate in the experimental animal. Arzneimettelforschung 1990; 40(3):319-23
35. Conte A, Volpi N, Palmieri L, et al. Biochemical and pharmacokinetic aspects of oral treatment with chondroitin sulfate. Arzneimittelforschung 1995; 45(8):918-25
36. Conte A, Palmieri L, Segnini D, Ronca G. Metabolic fate of partially depolymerized chondroitin sulfate administered to the rat. Drugs Exp Clin Res 1991; 17(1):27-33
37. Mazieres B, Loyau G, Menkes CJ, et al. Chondroitin sulfate in the treatment of gonarthrosis and coxarthrosis. 5-month result of a multicenter double-blind controlled prospective study using placebo. Rev Rhum Mal Osteoartic 1992; 59(7-8):466-472
38. Leeb BF, Petera P, Neumann K. Results of a multicenter study of chondroitin sulfate (Condrosulf) use in arthroses of the finger, knee and hip joints.Wien Med Wochenschr 1996; 146(24):609-614
39. Morreale P, Manopulo R, Galati M, et al. Comparison of the antiinflammatory efficacy of chondroitin sulfate and diclofenac sodium in patients with knee osteoarthritis. J Rheumatol 1996; 23(8):1385-91
40. Uebelhart D, Thonar EJ, Delmas PD, et al. Effects of oral chondroitin sulfate on the progression of knee osteoarthritis: a pilot study. Osteoarthritis Cartilage 1998; 6 (Suppl A):39-46
41. Bucsi L, Poor G. Efficacy and tolerability of oral chondroitin sulfate as a symptomatic slow-acting drug for osteoarthritis (SYSADOA) in the treatment of knee osteoarthritis. Osteoarthritis Cartilage 1998; 6 (Suppl A):31-36
42.Verbruggen G,Goemaere S,Veys EM. Chondroitin sulfate: S/DMOAD (structure/disease modifying antiosteoarthritis drug) in the treatment of finger joint OA.
Osteoarthritis Cartilage 1998; 6 (Suppl A):37-843. Bourgeois P, Chales G, Dehais J, et al. Efficacy and tolerability of chondroitin sulfate 1200 mg/day vs chondroitin sulfate 3 x 400 mg/day vs placebo. Osteoarthritis Cartilage 1998; 6 (Suppl A):25-30
44. Malaise M, Marcolongo R, Uebelhart D, Vignon E. Efficacy and tolerability of 800 mg oral Chondroitin 4&6 sulfate in the treatment of knee osteoarthritis: a randomised, double-blind, multicentre study versus placebo. Litera Rheumatologica 1999; 24:31-42
45. Conrozier T. Anti-arthrosis treatments: efficacy and tolerance of chondroitin sulfates. Presse Med 1998; 27(36):1862-5
46. Ronca F,Palmieri L,Panicucci P,Ronca G. Anti-inflammatory activity of chondroitin sulfate. Osteoarthritis Cartilage 1998; 6 (Suppl A):14-21
47.Kelly GS.The role of glucosamine sulfate and chondroitin sulfates in the treatment of degenerative joint disease. Altern Med Rev 1998; 3(1):27-39
48.Deal CL,Moskowitz RW.Neutraceuticals as therapeutic agents in osteoarthritis.The role of glucosamine, chondroitin sulfate, and collagen hydrolysate. Rheum Dis Clin North Am 1999; 25(2):379-95
49. Leffler CT, Philippi AF, Leffler SG, et al. Glucosamine, chondroitin, and manganese ascorbate for degenerative joint disease of the knee or low back: a randomized, double-blind, placebo-controlled pilot study. Mil Med 1999; 164(2):85-91
50. Rizzo R, Grandolfo M, Godeas C, et al. Calcium, sulfur, and zinc distribution in normal and arthritic articular equine cartilage: a synchrotron radiation-induced X-ray emission (SRIXE) study. J Exp Zool 1995; 273(1):82-6
51. di Padova C. S-adenosylmethionine in the treatment of osteoarthritis.Review of the clinical studies.Am J Med 1987; 83(5A):60-5 52. Maccagno A, Di Giorgio EE, Caston OL, Sagasta CL. Double-blind controlled clinical trial of oral Sadenosylmethionine versus piroxicam in knee osteoarthritis. Am J Med 1987; 83(5A):72-7
53. Caruso I, Pietrogrande V. Italian double-blind multicenter study comparing S-adenosylmethionine, naproxen, and placebo in the treatment of degenerative joint disease. Am J Med 1987; 83(5A):66-71
54. Glorioso S, Todesca S, Mazzi A, et al. Double-blind multicentre study of the activity of Sadenosylmethionine in hip and knee osteoarthritis. Int J Clin Pharmacol Res 1985; 5(1):39-49
55.Vetter G. Double-blind comparative clinical trial with S-adenosylmethionine and indomethacin in the treatment of osteoarthritis. Am J Med 1987; 83(5A):78-80
56. Konig B. A long-term (two year) clinical trial with S-adenosylmethionine for the treatment of osteoarthritis. Am J Med 1987; 83(5A):89-94
57. Harmand MF, Vilamitjana J, Maloche E, et al. Effects of S-adenosylmethionine on human articular chondrocyte differentiation. An in vitro study. Am J Med 1987; 83(5A):48-54
58. Gualano M, Berti F, Stramentinoli G. Anti-inflammatory activity of S-adenosyl-L-methionine in animal models: possible interference with the eicosanoid system. Int J Tissue React 1985; 7(1):41-6
59.Evans MS,Reid KH,Sharp JB Jr.Dimethylsulfoxide (DMSO) blocks conduction in peripheral nerve C fibers: a possible mechanism of analgesia. Neurosci Lett 1993; 150(2):145-8
60.Waddell PJ, Lawson SN. The C-fibre conduction block caused by capsaicin on rat vagus nerve in vitro. Pain 1989; 39(2):237-42
61. Eberhardt R, Zwingers T,Hofmann R. DMSO in patients with active gonarthrosis.A double-blind placebo controlled phase III study. Fortschr Med 1995; 113(31):446-50
62. Jacob SW, Lawrence RM, Zucker M. The Miracle of MSM. 1999.G.P. Putnam’s Sons; New York, NY
63. Murav’ev IuV, Venikova MS, Pleskovskaia GN. Effect of dimethyl sulfoxide and dimethyl sulfone on a destructive process in the joints of mice with spontaneous arthritis. Patol Fiziol Eksp Ter 1991; 2:37-39
64. Schwartz ER. The modulation of osteoarthritic development by vitamin C and E. Int J Vitam Nutr Res Suppl 1984; 26:141-6
65. Bolze MS, Reeves RD, Lindbeck FE, et al. Influence of manganese on growth, somatomedin and glycosaminoglycan metabolism. J Nutr 1985; 115(3):352-8
66.Yang P, Klimis-Tavantzis DJ. Effects of dietary manganese on arterial glycosaminoglycan metabolism in Sprague-Dawley rats. Biol Trace Elem Res 1998; 64(1-3):275-88
67. Masse PG, Ziv I, Cole DE, et al. A cartilage matrix deficiency experimentally induced by vitamin B6 deficiency. Proc Soc Exp Biol Med 1998; 217(1): 97-103
68. Talent JM,Gracy RW. Pilot study of oral polymeric N-acetyl-D-glucosamine as a potential treatment for patients with osteoarthritis. Clin Ther 1996; 18(6):1184-90
